DOCSLIB.ORG

Supplementary Table 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Supplementary Table 1: gene-fusion Category Chromosome type of fusion annotation of left partner annotations of right Fusion transcripts containing location of the partner one/both identified fusion partners § original genes other cancers HNSCC METTL13/DNM3 mRNA- 1q24.3/1q24.3 intra- METTL13 encodes for DNM3 encodes for METTL13/EIF4G3 no mRNA chromosomal methyltransferase like 13 dynamin, a member of a C1orf-9/DNM3 implicated in mRNA family of guanosine biogenesis, decay, and triphosphate (GTP)- translation control. binding proteins that associate with microtubules and are involved in vesicular transport. RCSD1/MPZL1 mRNA- 1q24.2/1q24.2 intra- RCSD1 encodes for RCSD MPZL1, also known as ATP1B1/RCSD1; no mRNA chromosomal domain containing 1 PZL, encodes for myelin MPZL1/PDE4DIP; protein. protein zero like 1, an DCAF6/MPZL1 immunoglobulin superfamily protein that specifically binds tyrosine phosphatase SHP-2 through its intracellular immunoreceptor tyrosine- based inhibitory motifs. CTNNA2/HES1 mRNA- 2p12-3/3q29 inter- CTNNA2 encodes for HES1 encodes for hes HIBCH/CTNNA2 GLIS3/CTNNA2 mRNA chromosomal catenin alfa cell-cell family bHLH PIGN/CTNNA2; translocation adhesion molecule that transcription factor 1. The MRLP35/CTNNA2 may function as a linker protein is a transcriptional POLR1A/CTNNA2 between cadherin adhesion repressor of genes that receptors and the require a bHLH protein cytoskeleton to regulate for their transcription. cell-cell adhesion and differentiation in the nervous system. ZC3H15/ITGAV mRNA- 2q32.1/2q32.1 intra- ZC3H15 encodes a ITGAV encodes the ZC3H15/SERINC1 no mRNA chromosomal potassium-dependent integrin subunit alfa V. ZC3H15/CPS1; GTPase The heterodimer ZC3H15/GULP1; consisting of alpha V and ITGAV/PDE11A; beta 3 subunits is also ITGAV/FARP2 known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression 24 FGF12/MB21D2 mRNA- 3q28-q29/3q29 intra- FGF12 encodes fibroblast MB21D2 encodes for FGF12/SYN3; no mRNA chromosomal growth factor 12. FGF Mab-21 domain TSC22D2/FGF12; family members possess containing 2 C1orf196/FGF12 broad mitogenic and cell survival activities. This growth factor lacks the N- terminal signal sequence present in most of the FGF family members, but it contains clusters of basic residues that have been demonstrated to act as a nuclear localization signal. FLNB/ENSG0000 mRNA- 3p14.3/4 inter- FLNB encodes a member antisense lnc-TET2-4 FLNB/SLMAP; no 0245384 lncRNA chromosomal of the filamin family, CCDC66/FLNB; translocation filamin b that interacts ABHD6/FLNB with glycoprotein Ib alpha as part of the process to repair vascular injuries. C9/RCOR1 mRNA- 5p13.1/14q32.31- inter- C9 encodes for the final RCOR1 encodes a protein RICTOR/C9; no mRNA q32.32 chromosomal component of the that is well-conserved, LIFR/C9; translocation complement system downregulated at birth, FAM157A/C9 and with a specific role in determining neural cell differentiation. The encoded protein binds to the C-terminal domain of REST (repressor element- 1 silencing transcription factor). RPS6KA2/RNAS mRNA- 6q27/6q27 intra- RPS6KA2 encodes a RNASET2 encodes a RPS6KA2/PSMG4 no ET2 mRNA chromosomal member of the RSK novel member of the (ribosomal S6 kinase) Rh/T2/S-glycoprotein family of serine/threonine class of extracellular kinases. This kinase ribonucleases. contains two non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen- activated kinase (MAPK) signalling pathway. 25 ANK1/KAT6A mRNA- 8p11.21/8p11.21 intra- ANK1 encodes for ankirin KAT6A encodes for ANK1/FUT10; no mRNA chromosomal 1, prototype of a family of lysine acetyltransferase ANK1/ADAM7; proteins that link the 6A, a member of the NECAP1/ANK1; integral membrane proteins MOZ, YBFR2, SAS2, TMEM188/ANK1; to the underlying spectrin- TIP60 family of histone WHSC1L1/ANK1; actin cytoskeleton and play acetyltransferases that IKBKB/ANK1; key roles in activities such acts as a co-activator for KIAA0146/ANK1; as cell motility, activation, several transcription PPFIA3/ANK1; proliferation, contact and factors KAT6A/IKBKB; the maintenance of KAT6A/KLK4; specialized membrane KAT6A/MSR1; domains. KAT6A/ADAM2; KAT6A/GOT1L1; KAT6A/RAB11F1P1 FAM49B/KAT6A; CHD7/KAT6A; CREBBP/KAT6A PVT1/ENSG0000 lncRNA- 8q24.21/8 intra- This gene represents a long intergenic LNC- no no 0253288 lncRNA chromosomal non-coding RNA locus that FAM135B-1:1 has been identified as a candidate oncogene. CD274/PDCD1LG2 mRNA- 9p24.1/9p24.1 intra- CD274 encodes for PDCD1LG2 encodes for KIAA1432/PDCD1 no mRNA chromosomal programmed death ligand programmed cell death 1 LG2 1, PD-L1, an immune ligand 2, PD-L2 inhibitory receptor ligand that is expressed by hematopoietic and non- hematopoietic cells, such as T cells and B cells and various types of tumor cells. MUSK/LPAR1 mRNA- 9q31.3/9q31.3 intra- MUSK encodes a muscle- LPAR1 encodes for a NAA15/LPAR1; no mRNA chromosomal specific tyrosine kinase lysophosphatidic acid SNX30/LPAR1 receptor. The encoded (LPA) receptor from a protein may play a role in group known as EDG clustering of the receptors that mediate acetylcholine receptor diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, 26 chemotaxis, and tumor cell invasion. DLG2/PICALM mRNA- 11q14.1/11q14.2 intra- DLG2 encodes for discs PICALM encodes for LRP5/DLG2; no mRNA chromosomal large MAGUK scaffold phosphatidylinositol ARRB1/DLG2; protein 2, a member of the binding clathrin assembly INPPSA/DLG2: membrane-associated protein that may be PLXNB2/DLG2: guanylate kinase required to determine the PICALM/RP11- (MAGUK) family. The amount of membrane to 849H4.2; encoded protein forms a be recycled, possibly by PICALM/MLLT10; heterodimer with a related regulating the size of the MLLT10/PICALM; family member that may clathrin cage. ARRB1/PICALM interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins NUMA1/GRIA3 mRNA- 11q13.4/Xq25 inter- NUMA1encodes for a GRIA3 encodes for NUMA1/FAM83B; NUMA1/SFN mRNA chromosomal large protein interacting glutamate ionotropic NUMA1/ADARB2; translocation with microtubules and receptor AMPA type NUMA1/PTH; playing a role in the subunit 3. The subunit NUMA1/AATF; formation and organization encoded by this gene NUMA1/PIPTNM1; of the mitotic spindle belongs to a family of NUMA1/PPP2R5B; during cell division. AMPA (alpha-amino-3- NUMA1/IQSEC3; hydroxy-5-methyl-4- NUMA1/TRPT1; isoxazole propionate)- NUMA1/ADHB12; sensitive glutamate NUMA1/CRYM; receptors, and is subject NUMA1/CCT5; to RNA editing (AGA- SHANK2/NUMA1; >GGA; R->G). STAG2/GRIA3 PPP6R3/MLL mRNA- 11q13.2/11q23.3 intra- SAPS3 encodes for the MLL,also known as PPP6R3/YAP1; no mRNA chromosomal phosphatase regulatory KMT2A lysine PPP6R3/POLD3; subunit 3 that modulates methyltransferase, PPP6R3/SSH2; the activity of phosphatase- encodes a transcriptional PPP6R3/FADD; 6 catalytic subunit by coactivator that plays an PPP6R3/SPTBN3; restricting substrate essential role in regulating PPP6R3/MTL5; specificity, recruiting gene expression during PPP6R3/LRP5; substrates, and determining early development and PPP6R3/ARHGAP1 the intracellular hematopoiesis. RNF121/PPP6R3; localization of the KDM2A/PPP6R3; holoenzyme. STRN3/PPP6R3; PC/PPP6R3; RAB11A/PPP6R3; CCDC132/PPP6R3; 27 MLL/ATP5L; MLL/SLC22A10; MLL/CD86; MLL/MLLT10; MLL/ELL; MLL/MLLT4; MLL/MLLT3; MLL/IGHMBP2: MLL/FYN; MLL/ZDHHC7; MLLT4/MLL; ENSG000002311 lncRNA- 12/12q21.2 intra- lnc-NAV3 NAV3 belongs to the CPSF6/NAV3; no 21/NAV3 mRNA chromosomal neuron navigator family PDK3/NAV3 and is expressed predominantly in the nervous system. The encoded protein contains coiled-coil domains and a conserved AAA domain characteristic for ATPases associated with a variety of cellular activities. ZMYM2/TRIM28 mRNA- 13q12.11/19q13.4 inter- ZMYM2 encodes for zinc TRIM28 encodes ZMYM2/MTMR6; no mRNA 3 chromosomal finger MYM-type tripartite motif containing ZMYM2/KIAA0564; translocation containing 2, also named 28 protein that mediates ZMYM2/DMRT2; ZNF118 that may act as a transcriptional control by TRIM28/ZBTB45 transcription facto and be interaction with the part of a BHC histone Kruppel-associated box deacetylase complex. repression domain found in many transcription factors. The protein localizes to the nucleus and is thought to associate with specific chromatin regions. TRAF3/ENSG000 mRNA- 14q32.32/14 intra- TRAF3 encodes for TNF long intergenic non- TRAF3/MYO16; TRAF3/CDC42 00259717 lncRNA chromosomal receptor associated factor 3, protein coding RNA 677 TRAF3/RCOR1; BPB a member of the TNF TRAF3/SFXN1; receptor associated factor TRAF3/BMP3; (TRAF) protein family. TRAF3/WDR20; TRAF proteins associate SLC22A23/TRAF3; with, and mediate the signal transduction from members of the TNF receptor (TNFR) 28 superfamily. This protein participates in the signal transduction of CD40, a TNFR family member important for the activation of the immune response. ENSG000002594 lncRNA- 15/15q13.3-q14 intra- intergenic lncRNA (lnc- The protein encoded by RYR3/LARP4; no 46/RYR3 mRNA chromosomal FMN1-4) this gene is a ryanodine RYR3/BUB1B; receptor, which functions LARP4/RYR3 to release calcium from intracellular storage for use in many cellular processes. WDR90/RHOT2 mRNA- 16p13.3/16p13.3 intra- WDR90 encodes for WD This gene encodes a WDR90/RAB40C; no mRNA chromosomal repeat domain 90 whose member of the Rho family KIAA1731/WDR90 function in humans
Recommended publications
  • Dynamin Functions and Ligands: Classical Mechanisms Behind

    Dynamin Functions and Ligands: Classical Mechanisms Behind

    1521-0111/91/2/123–134$25.00 http://dx.doi.org/10.1124/mol.116.105064 MOLECULAR PHARMACOLOGY Mol Pharmacol 91:123–134, February 2017 Copyright ª 2017 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW Dynamin Functions and Ligands: Classical Mechanisms Behind Mahaveer Singh, Hemant R. Jadhav, and Tanya Bhatt Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani Campus, Rajasthan, India Received May 5, 2016; accepted November 17, 2016 Downloaded from ABSTRACT Dynamin is a GTPase that plays a vital role in clathrin-dependent pathophysiology of various disorders, such as Alzheimer’s disease, endocytosis and other vesicular trafficking processes by acting Parkinson’s disease, Huntington’s disease, Charcot-Marie-Tooth as a pair of molecular scissors for newly formed vesicles originating disease, heart failure, schizophrenia, epilepsy, cancer, dominant ’ from the plasma membrane. Dynamins and related proteins are optic atrophy, osteoporosis, and Down s syndrome. This review is molpharm.aspetjournals.org important components for the cleavage of clathrin-coated vesicles, an attempt to illustrate the dynamin-related mechanisms involved phagosomes, and mitochondria. These proteins help in organelle in the above-mentioned disorders and to help medicinal chemists division, viral resistance, and mitochondrial fusion/fission. Dys- to design novel dynamin ligands, which could be useful in the function and mutations in dynamin have been implicated in the treatment of dynamin-related disorders. Introduction GTP hydrolysis–dependent conformational change of GTPase dynamin assists in membrane fission, leading to the generation Dynamins were originally discovered in the brain and identi- of endocytic vesicles (Praefcke and McMahon, 2004; Ferguson at ASPET Journals on September 23, 2021 fied as microtubule binding partners.
  • The Rise and Fall of the Bovine Corpus Luteum

    The Rise and Fall of the Bovine Corpus Luteum

    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
  • Sézary Syndrome Is a Unique Cutaneous T-Cell Lymphoma As

    Sézary Syndrome Is a Unique Cutaneous T-Cell Lymphoma As

    Leukemia (2008) 22, 393–399 & 2008 Nature Publishing Group All rights reserved 0887-6924/08 $30.00 www.nature.com/leu ORIGINAL ARTICLE Se´zary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3 N Booken1,11, A Gratchev1,11, J Utikal1, C Wei2,XYu3, M Qadoumi1, M Schmuth4, N Sepp4, D Nashan5, K Rass6,TTu¨ting7, C Assaf8, E Dippel1,9, R Stadler10, C-D Klemke1 and S Goerdt1 1Department of Dermatology, Venereology and Allergology, University Medical Centre Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany; 2Institute of Medical Statistics, University Medical Centre Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany; 3Medical Research Center (ZMF), University Medical Centre Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany; 4Department of Dermatology, Innsbruck Medical University, Innsbruck, Austria; 5Department of Dermatology, University of Freiburg, Freiburg, Germany; 6Department of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany; 7Department of Dermatology, University of Bonn, Bonn, Germany; 8Department of Dermatology, Charite-University Medicine Berlin, Berlin, Germany; 9Department of Dermatology, Academic Medical Centre, Lemgo, Germany and 10Department of Dermatology, Academic Medical Centre, Minden, Germany Sezary syndrome (SS) is a rare, aggressive CD4 þ cutaneous While MF usually is a slowly progressive disease, SS runs a more T-cell lymphoma (CTCL); molecular traits differentiating SS aggressive course with a high mortality rate and a median survival from nonleukemic mycosis fungoides (MF) and from inflamma- time of 2–4 years. The probability of survival in CTCL can be tory skin diseases (ID) are not sufficiently characterized.
  • Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’S Disease

    Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’S Disease

    cells Review Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease Giulia Lamonaca and Mattia Volta * Institute for Biomedicine, Eurac Research-Affiliated Institute of the University of Lübeck, 39100 Bolzano, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0471-055483 Received: 4 April 2020; Accepted: 23 April 2020; Published: 30 April 2020 Abstract: The lack of effective disease-modifying strategies is the major unmet clinical need in Parkinson’s disease. Several experimental approaches have attempted to validate cellular targets and processes. Of these, autophagy has received considerable attention in the last 20 years due to its involvement in the clearance of pathologic protein aggregates and maintenance of neuronal homeostasis. However, this strategy mainly addresses a very late stage of the disease, when neuropathology and neurodegeneration have likely “tipped over the edge” and disease modification is extremely difficult. Very recently, autophagy has been demonstrated to modulate synaptic activity, a process distinct from its catabolic function. Abnormalities in synaptic transmission are an early event in neurodegeneration with Leucine-Rich Repeat Kinase 2 (LRRK2) and alpha-synuclein strongly implicated. In this review, we analyzed these processes separately and then discussed the unification of these biomolecular fields with the aim of reconstructing a potential “molecular timeline” of disease onset and progression. We postulate that the elucidation of these pathogenic mechanisms will form a critical basis for the design of novel, effective disease-modifying therapies that could be applied early in the disease process. Keywords: LRRK2; autophagy; Parkinson’s disease; alpha-synuclein; synaptic transmission; neuropathology 1.
  • Molecular Dynamics and Evolutionary Aspects of the Transition from the Fully Grown Oocyte to Embryo

    Molecular Dynamics and Evolutionary Aspects of the Transition from the Fully Grown Oocyte to Embryo

    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo Alexei V. Evsikov,1,5 Joel H. Graber,1 J. Michael Brockman,1,2 Aleš Hampl,3 Andrea E. Holbrook,1 Priyam Singh,1,2 John J. Eppig,1 Davor Solter,1,4 and Barbara B. Knowles1 1The Jackson Laboratory, Bar Harbor, Maine 04609, USA; 2 Bioinformatics Program, Boston University, Boston, Massachusetts 02215, USA; 3Masaryk University Brno and Institute of Experimental Medicine, 625 00 Brno, Czech Republic; 4Max Planck Institute of Immunobiology, 79108 Freiburg, Germany Fully grown oocytes (FGOs) contain all the necessary transcripts to activate molecular pathways underlying the oocyte-to-embryo transition (OET). To elucidate this critical period of development, an extensive survey of the FGO transcriptome was performed by analyzing 19,000 expressed sequence tags of the Mus musculus FGO cDNA library. Expression of 5400 genes and transposable elements is reported. For a majority of genes expressed in mouse FGOs, homologs transcribed in eggs of Xenopus laevis or Ciona intestinalis were found, pinpointing evolutionary conservation of most regulatory cascades underlying the OET in chordates. A large proportion of identified genes belongs to several gene families with oocyte-restricted expression, a likely result of lineage-specific genomic duplications. Gene loss by mutation and expression in female germline of retrotransposed genes specific to M. musculus is documented. These findings indicate rapid diversification of genes involved in female reproduction. Comparison of the FGO and two-cell embryo transcriptomes demarcated the processes important for oogenesis from those involved in OET and identified novel motifs in maternal mRNAs associated with transcript stability.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Leukaemia Section

    Leukaemia Section

    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Mini Review t(11;11)(q14;q23) KMT2A/PICALM inv(11)(q14q23) KMT2A/PICALM Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France. jean- [email protected] Published in Atlas Database: March 2017 Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t1111q14q23ID1411.html Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/68879/03-2017-t1111q14q23ID1411.pdf DOI: 10.4267/2042/68879 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2018 Atlas of Genetics and Cytogenetics in Oncology and Haematology Otherwise, in a large study of cases of chromosomal Abstract rearrangements involving the human KMT2A Review on t(11;11)(q14;q23) and inv(11)(q14q23) (MLL) gene, a t(11;11)(q14;q23) or inv(11)(q14q23) KMT2A/PICALM, with data on clinics and the KMT2A/PICALM was found in 1 out of 440 infant genes involved. ALL patients, 1 out of 105 infant AML patients, 1 KEYWORDS out of 205 pediatric ALL patients, 1 out of 272 adult Chromosome 11; KMT2A; PICALM; acute myeloid AML patients, and none in 202 pediatric AML leukemia; acute lymphoblastic leukemia. patients, nor in 333 adult ALL patients (Meyer et al., 2013). Note: the case by Meyer et al., 2006 was Clinics and pathology reused in Meyer et al., 2013. Disease Genes involved and Acute myeloid leukemia (AML) and acute proteins lymphoblastic leukemia (ALL). Clinics PICALM (clathrin assembly lymphoid myeloid leukemia gene) There was the case of a 12-week-old female infant with acute monocytic leukemia (M5b) and Location inv(11)(q14q23), dead at day 11 (Wechsler et al., 11q14.2 2003).
  • Supplemental Information

    Supplemental Information

    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT

    WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
  • UNIVERSITY of CALIFORNIA RIVERSIDE Investigations Into The

    UNIVERSITY of CALIFORNIA RIVERSIDE Investigations Into The

    UNIVERSITY OF CALIFORNIA RIVERSIDE Investigations into the Role of TAF1-mediated Phosphorylation in Gene Regulation A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Cell, Molecular and Developmental Biology by Brian James Gadd December 2012 Dissertation Committee: Dr. Xuan Liu, Chairperson Dr. Frank Sauer Dr. Frances M. Sladek Copyright by Brian James Gadd 2012 The Dissertation of Brian James Gadd is approved Committee Chairperson University of California, Riverside Acknowledgments I am thankful to Dr. Liu for her patience and support over the last eight years. I am deeply indebted to my committee members, Dr. Frank Sauer and Dr. Frances Sladek for the insightful comments on my research and this dissertation. Thanks goes out to CMDB, especially Dr. Bachant, Dr. Springer and Kathy Redd for their support. Thanks to all the members of the Liu lab both past and present. A very special thanks to the members of the Sauer lab, including Silvia, Stephane, David, Matt, Stephen, Ninuo, Toby, Josh, Alice, Alex and Flora. You have made all the years here fly by and made them so enjoyable. From the Sladek lab I want to thank Eugene, John, Linh and Karthi. Special thanks go out to all the friends I’ve made over the years here. Chris, Amber, Stephane and David, thank you so much for feeding me, encouraging me and keeping me sane. Thanks to the brothers for all your encouragement and prayers. To any I haven’t mentioned by name, I promise I haven’t forgotten all you’ve done for me during my graduate years.
  • Differential Regulation of Estrogen Receptor Α Expression in Breast

    Differential Regulation of Estrogen Receptor Α Expression in Breast

    Author Manuscript Published OnlineFirst on January 10, 2014; DOI: 10.1158/0008-5472.CAN-13-2020 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. CAN-13-2020R Differential Regulation of Estrogen Receptor α Expression in Breast Cancer Cells by Metastasis-Associated Protein 1 Hyun-Jin Kang1, Min-Ho Lee1, Hae-Lim Kang1, Sung-Hae Kim1, Jung-Ranh Ahn1, Hyelin Na1, Tae-Young Na1, Yona Kim2, Je Kyung Seong2, and Mi-Ock Lee1 1College of Pharmacy and Bio-MAX institute, Research Institute of Pharmaceutical Sciences; and 2College of Veterinary Medicine, BK21 Plus Program for Veterinary Science, Seoul National University, Seoul, Korea; Keywords: Estrogen receptor α; MTA1; IFI16; epigenetics, hormone sensitivity Hyun-Jin Kang, Min-Ho Lee, and Hae-Lim Kang contributed equally to this work. Corresponding Authors: Mi-Ock Lee Ph. D., College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. Phone: 82-2-880-9331; Fax: 82-2-887-2692; E-mail: [email protected] Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research. Author Manuscript Published OnlineFirst on January 10, 2014; DOI: 10.1158/0008-5472.CAN-13-2020 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. ABSTRACT Metastasis-associated protein 1 (MTA1) is a component of the nucleosome remodeling and histone deacetylase (HDAC) complex, which plays an important role in progression of breast cancer. Although MTA1 is known as a repressor of the transactivation function of estrogen receptor (ER)α, its involvement in the epigenetic control of transcription of the ERα gene ESR1 has not been studied.
  • Supporting Information

    Supporting Information

    Supporting Information The deubiquitinase USP38 promotes NHEJ repair through regulation of HDAC1 activity and regulates cancer cell response to genotoxic insults Yongfeng Yang1,2, Chuanzhen Yang1，2, Tingting Li3, Shuyu Yu1,2,Tingting Gan4, Jiazhi Hu4, Jun Cui5,6, and Xiaofeng Zheng1,2,* 1 State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China. 2Department of Biochemistry and Molecular Biology, School of Life Sciences, Peking University, Beijing, China. 3State Key Laboratory of Proteomics, National Center of Biomedical Analysis, Institute of Basic Medical Sciences, Beijing, China. 4Department of Cell Biology, School of Life Sciences, Peking University, Beijing, China. 5Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China. 6Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, China. *To whom correspondence should be addressed. Xiaofeng Zheng, School of Life Sciences, Peking University, Beijing 100871, China. Tel: +86 10-6275-5712; Email: [email protected] Supplementary Materials and Methods: Antibodies and reagents Mouse monoclonal anti-Flag (F3165, RRID: AB_259529) antibodies, anti-HA (H9658, RRID: AB_260092) antibodies, and etoposide (E1383) were purchased from Sigma-Aldrich. Mouse monoclonal anti-Myc (M047-3, RRID: AB_591112), anti-histidine (D291–3, RRID: AB_10597733), and rabbit polyclonal anti-β-actin (PM053, RRID: AB_10598196) antibodies were purchased from MBL. Mouse monoclonal anti-H3 (BE3015) antibodies were purchased from EASYBIO. Mouse monoclonal anti-γH2AX (05–636, RRID: AB_309864) antibodies and MG132 (2772605) were purchased from Millipore. Mouse monoclonal anti-HDAC1 (sc-81598, RRID: AB_2118083) antibodies were purchased from Santa Cruz Biotechnology.